prednisone has been researched along with procainamide in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (62.86) | 18.7374 |
1990's | 1 (2.86) | 18.2507 |
2000's | 9 (25.71) | 29.6817 |
2010's | 3 (8.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bicíková, L | 1 |
Warner, WA | 1 |
Erickson, DG; Foucar, E; Tung, KS | 1 |
Bernheim, J; Blanc-Brunat, N; Colon, S; Labeeuw, M; Zech, P | 1 |
Diaz, R; Quigley, TJ; Rao, KV | 1 |
Ghose, MK | 1 |
Shah, A; Sunder, SK | 1 |
Auerbach, RC; Bragg, DG; Snyder, NE | 1 |
Blomgren, SE; Condemi, JJ; Vaughan, JH | 1 |
Ghorra, F; Hannouche, G; Mamo, A; Taleb, N | 1 |
Tabbara, RA; Uthman, SM | 1 |
Blomgren, SE | 1 |
Walton, JN | 1 |
Eliot, RS; Ferlic, RM; Lillehei, CW; Sellers, RD | 1 |
Carr, GA; Doolan, TJ; Russell, PJ; Webb, J | 1 |
Kosfeld, RE; Leight, L; Liu, YK; Rosenstein, R | 1 |
Marino, C; McDonald, E | 1 |
LEYBURN, P; WALTON, JN | 1 |
LUND, H | 1 |
BELLET, S | 1 |
CZARNECKI, SW; KAPLAN, JM; SAMPSON, JJ; WACHTEL, HL | 1 |
4 review(s) available for prednisone and procainamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature.
Topics: Azathioprine; Biopsy; Glomerulonephritis; Humans; Kidney Glomerulus; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisone; Procainamide; Ventricular Dysfunction | 1979 |
Systemic lupus erythematosus.
Topics: Antibodies, Antinuclear; Arthritis, Rheumatoid; Female; Hepatitis; Humans; Hydralazine; Immunoglobulins; Kidney; Lupus Erythematosus, Systemic; Male; Nephritis; Neutrophils; Prednisone; Procainamide; Prognosis; Skin | 1973 |
Procainamide-induced lupus in the elderly.
Topics: Aged; Antibodies, Antinuclear; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Male; Physical Examination; Prednisone; Procainamide | 1993 |
31 other study(ies) available for prednisone and procainamide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Effect of drugs on the stimulation threshold of the human heart.
Topics: Adrenergic beta-Antagonists; Ajmaline; Anesthetics, Local; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Digitalis Glycosides; Heart Ventricles; Humans; Hydrocortisone; Lidocaine; Nandrolone; Nitrites; Phenytoin; Prednisone; Procainamide; Purines; Quinidine; Trimecaine | 1978 |
Drug-induced lupus erythematosus.
Topics: Aged; Antibodies, Antinuclear; Arrhythmias, Cardiac; Humans; Lupus Erythematosus, Systemic; Male; Neutrophils; Pericarditis; Pleurisy; Prednisone; Procainamide | 1977 |
Procainamide-induced lupus.
Topics: Aged; Arrhythmias, Cardiac; Cardiomegaly; Drainage; Drug Therapy, Combination; Factor XI Deficiency; Humans; Hydrocortisone; Lupus Erythematosus, Systemic; Male; Pleural Effusion; Prednisone; Procainamide; Pulmonary Atelectasis; Radiography | 1976 |
Nephrotic syndrome in procainamide induced lupus nephritis.
Topics: Aged; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Nephritis; Nephrotic Syndrome; Prednisone; Procainamide; Syndrome | 1979 |
Procainamide-induced systemic lupus erythematosus with hypocomplementemia.
Topics: Aged; Complement System Proteins; Digoxin; Female; Humans; Lupus Erythematosus, Systemic; Prednisone; Procainamide | 1977 |
Pericardial tamponade. A presenting manifestation of procainamide-induced lupus erythematosus.
Topics: Aged; Cardiac Tamponade; Humans; Lupus Erythematosus, Systemic; Male; Pericardial Effusion; Pericarditis; Prednisone; Procainamide; Radiography | 1975 |
Constrictive pericarditis in procainamide-induced lupus erythematosus syndrome.
Topics: Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pericarditis, Constrictive; Prednisone; Procainamide | 1975 |
The chest roentgenographic manifestations of Pronestyl-induced lupus erythematosus.
Topics: Aged; Antibodies, Antinuclear; Arrhythmias, Cardiac; Cardiomegaly; Cardiomyopathies; Female; Heart; Heart Failure; Humans; Lupus Erythematosus, Systemic; Middle Aged; Pleural Effusion; Prednisone; Procainamide; Radiography | 1973 |
Procainamide-induced lupus erythematosus. Clinical and laboratory observations.
Topics: Animals; Antibodies, Antinuclear; Antibody Formation; Autoimmune Diseases; Cattle; Complement Fixation Tests; DNA; Female; Histones; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Nucleic Acid Conformation; Nucleic Acid Denaturation; Nucleoproteins; Pleurisy; Precipitin Tests; Prednisone; Procainamide; Rabbits; Rheumatoid Factor; Tritium | 1972 |
[S-thalassemia. Apropos of 40 case reports in Lebanon].
Topics: Electrocardiography; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Pericardial Effusion; Prednisone; Procainamide | 1973 |
Drug-induced lupus syndrome presenting as pericardia effusion.
Topics: Electrocardiography; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Pericardial Effusion; Prednisone; Procainamide | 1973 |
Drug-induced lupus erythematosus.
Topics: Antibodies; Cell Membrane; DNA; Drug Hypersensitivity; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; Prednisone; Procainamide | 1973 |
Muscular dystrophies and their management.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Muscular Dystrophies; Myotonia; Phenytoin; Prednisone; Procainamide; Respiratory Tract Infections | 1969 |
Cardioversion as an adjunct to cardiac surgery.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Chronic Disease; Drug Hypersensitivity; Electric Countershock; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Phenytoin; Postoperative Care; Prednisone; Preoperative Care; Procainamide; Quinidine; Rheumatic Heart Disease; Thromboembolism; Time Factors | 1967 |
Studies of autologous mixed lymphocyte reactions in patients with systemic lupus erythematosus.
Topics: Adult; Aged; Antibodies; DNA; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Phytohemagglutinins; Polyarteritis Nodosa; Prednisone; Procainamide; Sjogren's Syndrome; T-Lymphocytes | 1983 |
Procainamide-induced thrombocytopenia.
Topics: Aged; Female; Humans; Platelet Count; Prednisone; Procainamide; Thrombocytopenia | 1984 |
The treatment of myotonia: a controlled clinical trial.
Topics: Humans; Myotonia; Prednisone; Procainamide; Quinine | 1959 |
[SUPRAVENTRICULAR TACHYCARDIA AS A COMPLICATION OF MYOCARDIAL INFARCT TREATED WITH PREDNISONE].
Topics: Adrenal Cortex Hormones; Digitoxin; Electrocardiography; Myocardial Infarction; Myocardium; Pharmacology; Prednisone; Procainamide; Quinidine; Tachycardia; Tachycardia, Supraventricular | 1964 |
THE DRUG TREATMENT OF COMPLETE A-V HEART BLOCK.
Topics: Adams-Stokes Syndrome; Amphetamine; Atropine; Blood Chemical Analysis; Chlorothiazide; Cortisone; Digitalis; Digitalis Glycosides; Drug Therapy; Ephedrine; Epinephrine; Heart Block; Humans; Isoproterenol; Lactates; Methantheline; Norepinephrine; Pacemaker, Artificial; Physical Exertion; Potassium; Prednisone; Procainamide; Quaternary Ammonium Compounds; Quinidine; Stress, Physiological | 1964 |
LUPUS-LIKE ILLNESS PRECIPITATED BY PROCAINAMIDE HYDROCHLORIDE.
Topics: Arrhythmias, Cardiac; Autoimmune Diseases; Coombs Test; Diagnosis; Digoxin; Drug Therapy; Geriatrics; Humans; Joint Diseases; Lupus Erythematosus, Systemic; Prednisone; Procainamide; Splenomegaly; Toxicology | 1965 |